SVF Investments (UK) Ltd, Former 10% Owner at Arbutus Biopharma, holds 349.54M shares in Coupang (Ticker: CPNG), holds 73.03M shares in Roivant Sciences (Ticker: ROIV), holds 22.86M shares in Urovant Sciences (Ticker: UROV). Most recently, SVF Investments (UK) Ltd Sold ― shares of Coupang on Mar 14, 2024 for an estimated value of 894.93M.
What was SVF Investments (UK) Ltd’s latest transaction?
SVF Investments (UK) Ltd latest transaction was an Informative Sell of $894.93M.
What was SVF Investments (UK) Ltd's most profitable transaction?
SVF Investments (UK) Ltd’s most profitable transaction was an Informative Buy of ABUS stock on September 14, 2017. The return on the trade was 102.10%.
What is SVF Investments (UK) Ltd's role in Arbutus Biopharma?
SVF Investments (UK) Ltd's role in Arbutus Biopharma is Former 10% Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.